Features
Spectrum Medical Imaging Co. supports healthcare providers with reliable access to CLARISCAN INJECTION 10mL 0.5mm, a trusted gadolinium-based contrast media used in precise medical imaging services.
As a trusted contrast media supplier, we deliver the diagnostic imaging supplies, imaging accessories, and expert support needed to ensure efficient workflows and exceptional patient care across hospitals, outpatient centers, and private practices.
Magnetic resonance imaging (MRI) is a cornerstone of modern diagnostics, providing detailed images of the body’s internal structures. To enhance the visibility of specific tissues and pathologies, contrast agents are frequently used. Gadolinium-based contrast agents are paramagnetic substances that alter the relaxation times of water protons, resulting in signal enhancement in T1-weighted MRI images.
CLARISCAN INJECTION 10mL 0.5mm, powered by gadoterate meglumine, is a macrocyclic gadolinium-based contrast agent formulated to enhance diagnostic precision in modern medical imaging services. Its proven performance supports consistent, high-quality MRI results for a wide range of clinical applications.
Whether you’re supporting advanced neuroimaging or routine diagnostic exams, CLARISCAN INJECTION 10mL 0.5mm offers reliability, clarity, and versatility for use across today’s reliable medical imaging services.
Ensuring precision in dosing and administration is vital in radiology. CLARISCAN INJECTION 10mL 0.5mm supports consistent radiologic results through its reliable formulation and packaging, crucial for effective contrast media in radiology protocols.
The 10 mL volume of CLARISCAN INJECTION 10 mL 0.5mm provides an efficient mid-range dose suitable for a variety of contrast media in radiology protocols, based on patient weight and the specific imaging study. This standardized volume helps streamline preparation and administration procedures, contributing to consistent radiologic results.
As a macrocyclic gadolinium-based contrast agent, gadoterate meglumine exhibits high stability. Studies have shown that macrocyclic agents like Clariscan have a low propensity for gadolinium retention in body tissues compared to linear Gadolinium-based contrast media, addressing concerns for both patients and healthcare providers. This safety profile is an important consideration for medical imaging services performing contrast-enhanced MRI.
Securing essential contrast agents like CLARISCAN INJECTION 10mL 0.5mm is critical to the success of today’s medical imaging services. As a reliable contrast media supplier, Spectrum Medical Imaging Co. brings 40 years of industry experience to help healthcare professionals streamline procurement, reduce costs, and maintain clinical efficiency.
Whether you’re managing a busy outpatient center or a high-volume hospital imaging suite, you can count on Spectrum Medical Imaging Co. to deliver the contrast solutions and technical expertise needed to power your medical imaging services with confidence.
Ensure your medical imaging services have consistent access to CLARISCAN INJECTION 10mL 0.5mm with fast delivery and expert support from Spectrum Medical Imaging Co. As a trusted contrast media supplier, we offer competitive pricing, dependable inventory, and specialized services, including contrast injector repair and maintenance, to keep your operations running smoothly. Contact us today to request a quote, review technical details, or streamline your procurement strategy with our dedicated support team.
CLARISCAN is a macrocyclic gadolinium-based contrast agent that contains gadoterate meglumine. It is used for contrast MRI procedures to enhance the visualization of soft tissues and detect abnormalities with greater clarity.
CLARISCAN INJECTION 10mL is administered via intravenous injection by trained medical personnel. Its pre-filled syringe format helps ensure accurate dosing and streamlined preparation for contrast MRI scans.
Yes, adverse reactions may occur, though they are typically mild and short-lived. Common reactions include headache, nausea, and injection site discomfort. As with all gadolinium-based agents, rare but serious hypersensitivity reactions are possible and should be monitored.
Macrocyclic gadolinium-based contrast agents are known for their strong molecular stability, reducing the risk of gadolinium release into the body. This makes CLARISCAN, which contains gadoterate meglumine, a preferred choice for patients requiring contrast MRI, especially those at higher risk.
